Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Sarepta Therapeutics, Inc.

CIK 873303 SRPT·Pharmaceutical Preparations · All EDGAR filings ↗

Accounting standard newly cited Filing comparison

Sarepta Therapeutics, Inc. cited accounting standard ASU 2020-06 for the first time in this filing series

The Company early adopted ASU 2024-04, effective January 1, 2025 as permitted for entities that have previously adopted ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.
Evidence
Adopted
2020-06
Adoption year stated
2025
Contexts
The Company early adopted ASU 2024-04, effective January 1, 2025 as permitted for entities that have previously adopted ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.
New standards
2020-06, 2024-04, 2025-06, 2025-07
Prior filed
2025-02-28
Prior form
10-K
Restates existing policy
No
Source
accounting standards update (ASU) reference comparison
Why
An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.